Overview #
Broad-spectrum protection is not just about SPF number. The SPF value tells you almost nothing about UVA coverage — and that gap is where most formulation failures happen. In our lab, we treat critical wavelength, UVA-PF, and PA rating as three separate engineering targets, each with its own filter selection logic, stability constraint, and regulatory pathway. Getting all three right simultaneously is harder than most brand briefs suggest. This guide covers what we actually watch in the stability chamber and on the production line.
How We Define “Broad-Spectrum” in Practice #
SPF measures UVB protection. Full stop. Broad-spectrum means you’ve also covered UVA — but the threshold varies by market, and that matters enormously when you’re building a single global SKU.
In the US, FDA Cosmetics Guidelines require a critical wavelength ≥ 370 nm to make a broad-spectrum claim. In the EU, EU Cosmetics Regulation 1223/2009 requires UVA-PF to be at least one-third of the labeled SPF — so an SPF 50 product must achieve UVA-PF ≥ 16.7. Japan’s PA system runs on a separate JCIA protocol entirely, with PA++++ requiring UVA-PF ≥ 16. China’s NMPA Cosmetic Regulation requires both SPF and PFA (persistent pigment darkening) testing for any UVA claim, with its own approved filter list that doesn’t fully overlap with the EU or US.
This is usually where global SKU projects go sideways. A filter combination that clears FDA broad-spectrum easily can still miss the EU UVA-PF ratio at SPF 50+. We’ve had brand partners come to us with a “globally compliant” formula from another supplier that failed EU UVA-PF by a margin of 3 points. Not catastrophic, but enough to require a reformulation.
The practical fix is to design for the most restrictive market first — typically EU UVA-PF ratio — and verify critical wavelength as a secondary check. In our experience, if you hit UVA-PF ≥ 18 on an SPF 50 formula, critical wavelength almost always clears 370 nm. Almost.
Filter Selection and the Stability Problem Nobody Talks About Upfront #
This is where the real formulation work happens. Filter selection isn’t just about absorption spectrum — it’s about what survives 12 months in a tube at 40°C.
Avobenzone (butyl methoxydibenzoylmethane) is the workhorse UVA filter in the US market. It absorbs strongly at 360 nm, which is exactly what you need. The problem: it photodegrades. Unprotected avobenzone loses roughly 50–90% of its UV absorbance after 1 hour of UV exposure depending on the formulation matrix. We stabilize it with photostabilizers — octocrylene at 2–3% is the standard approach, or Tinosorb S (bis-ethylhexyloxyphenol methoxyphenyl triazine) if the formula is going to EU markets where octocrylene’s safety review is still evolving under SCCS Scientific Opinion scrutiny.
Tinosorb M and Tinosorb S are our preferred broad-spectrum anchors for EU-targeted formulas. Tinosorb S covers UVA and UVB with a broad absorption peak, is photostable, and doesn’t require a photostabilizer partner. The catch: it’s not FDA-approved. So for US market, you’re back to avobenzone-based systems, and the photostabilization chemistry becomes critical.
Zinc oxide is the cleanest broad-spectrum option from a regulatory standpoint — approved everywhere, photostable, no photodegradation concern. But achieving SPF 30+ with zinc oxide alone requires particle loading above 20%, which creates a white cast problem that most brand partners won’t accept. We typically run zinc oxide at 10–15% in combination with organic filters to balance coverage and aesthetics. For mineral-only formulas, our mineral UV technology documentation covers the particle size and dispersion work in more detail.
| Filter | UVA Coverage | Photostability | Key Regulatory Constraint |
|---|---|---|---|
| Avobenzone (3%) | UVA I (340–400 nm) | Poor — requires photostabilizer | FDA max 3%; EU max 5% |
| Tinosorb S (2%) | UVA + UVB broad | Excellent — self-stabilizing | Not FDA-approved |
| Zinc Oxide (15–20%) | UVA I + II | Excellent | FDA max 25%; EU nano rules apply |
| Mexoryl SX (2%) | UVA II (320–340 nm) | Good | EU approved; not FDA-approved |
| Octocrylene (5%) | UVB + photostabilizer | Good | SCCS under review; EU max 9% |
One combination we’ve stopped recommending: avobenzone + titanium dioxide in the same emulsion without careful pH control. TiO₂ can catalyze avobenzone degradation through a photocatalytic mechanism, especially at higher temperatures. We’ve seen this failure mode in accelerated stability — the formula looks fine at week 4, then SPF drops 15–20% by week 12 at 40°C. By that point the brand has already printed packaging.
Degradation Conditions: What the Stability Chamber Actually Tells Us #
We run all sunscreen stability under ICH Stability Guidelines conditions as a baseline — 40°C/75% RH for accelerated, 25°C/60% RH for long-term — but sunscreen formulas have additional failure modes that standard ICH protocols don’t fully capture.
Temperature is the primary driver of emulsion instability. Above 45°C, most O/W emulsions with high filter loading start showing phase separation within 4–6 weeks. We’ve had one batch — a tinted SPF 50 fluid with 18% total filter load — that was perfectly stable at 40°C for 12 weeks but failed catastrophically at 50°C by week 3. The emulsifier system couldn’t handle the combined thermal stress and filter-emulsifier interaction at that temperature. We rebuilt the emulsifier blend and it passed. But that’s a 6-week delay on a launch timeline.
pH matters more than most brands realize. Organic acid-based filters like Mexoryl SX are pH-sensitive — below pH 5.5, you start seeing solubility issues. Above pH 7.5, avobenzone stability drops noticeably. Our target window for most broad-spectrum formulas is pH 6.0–7.0. That range also happens to be compatible with most skin-feel polymers and emollients, so it’s not usually a constraint — until someone asks us to add a vitamin C derivative or an AHA into the same formula.
That combination — high-SPF + low-pH actives — is one we push back on almost every time. Ascorbic acid at effective concentrations (typically 10–20%) requires pH 3.0–3.5. That’s incompatible with most organic filter systems. We can sometimes make it work with encapsulated vitamin C or ascorbyl glucoside at higher pH, but the performance trade-off is real. Our vitamin C and antioxidant systems page covers the encapsulation options in detail.
Fragrance is another failure point. Fragrance load above 0.8% in high-SPF emulsions consistently causes problems in our lab — either emulsion destabilization or filter-fragrance interactions that shift the UV absorption profile. We cap fragrance at 0.5% in any formula with SPF 30+. Some clients push back on this. We hold the line.
| Stability Parameter | Acceptable Range | Failure Threshold | Notes |
|---|---|---|---|
| pH | 6.0–7.0 | < 5.5 or > 7.5 | Mexoryl SX solubility; avobenzone stability |
| Storage Temperature | ≤ 40°C (accelerated) | > 45°C sustained | Emulsion phase separation risk |
| Fragrance Load | ≤ 0.5% | > 0.8% | Filter-fragrance interaction; emulsion stress |
| Total Filter Load | 15–22% | > 25% | Viscosity, skin feel, emulsifier demand |
| Avobenzone (if used) | 2–3% with photostabilizer | > 3% without stabilizer | Photodegradation; FDA max 3% |
| Accelerated Stability | 40°C/75% RH, 12 weeks | SPF drop > 15% | ICH-aligned; in-use SPF retention |
The Clinical Evidence Question #
Brand partners often ask us whether their SPF 50 formula will “perform like SPF 50 in real life.” Honest answer: it depends on application thickness, and most consumers apply far less than the 2 mg/cm² used in ISO 24444 testing.
One well-designed study (n=52, randomized, 12-week daily use, SPF 50 sunscreen applied ad libitum) found that actual photoprotection achieved in real-world use corresponded to approximately SPF 15–20 — roughly one-third of the labeled value. This is consistent with what we see when we run consumer-use simulations internally. The labeled SPF is a lab number. Real-world protection is a behavior number.
This doesn’t mean SPF 50 is misleading — it means the formula needs to support easy, adequate application. Skin feel, spreadability, and finish all drive compliance. A formula that consumers actually use generously outperforms a technically superior formula that feels heavy and gets underapplied. We factor this into our texture development work from the start.
For UVA specifically, the PA+++ / PA++++ rating system gives consumers a clearer signal than UVA-PF numbers. PA+++ corresponds to UVA-PF 8–15; PA++++ corresponds to UVA-PF ≥ 16. In Asian markets especially, PA rating is a primary purchase driver. We design for PA++++ as the default target on any SPF 50+ formula going to Japan, Korea, or China.
Packaging: Where Stability Work Gets Undone #
We’ve seen formulas pass 12 months of stability testing in one packaging format and fail in another. This is not rare. It’s actually one of the more common late-stage surprises in sunscreen development.
The main culprits are oxygen permeation and UV transmission through the container. Organic filters — especially avobenzone — are sensitive to both. A clear PET bottle with no UV inhibitor can transmit enough ambient light to degrade avobenzone at the container wall, creating a concentration gradient that eventually affects the bulk. We now require UV-blocking packaging (either opaque, or PET with UV inhibitor additive) for any formula containing avobenzone or other photolabile filters. We rejected one packaging vendor last year specifically because their “UV-blocking” PET tested at only 40% UV transmission reduction — not sufficient.
Airless pump packaging is the gold standard for high-SPF formulas. It eliminates headspace oxygen, prevents contamination, and maintains consistent dose delivery. The cost reality: airless pump adds $0.40–$0.80 per unit at MOQ 3,000–5,000 units. For indie brands launching at MOQ 1,000, that’s often not viable. In those cases, we recommend aluminum tubes with an internal lacquer coating as the next-best option — good oxygen barrier, UV-opaque, and cost-effective at lower MOQs.
Pump bottles with dip tubes are the worst option for high-SPF emulsions with significant mineral content. Zinc oxide settles. By the time the consumer reaches the bottom third of the bottle, the formula is no longer homogeneous and SPF is unpredictable. We’ve stopped recommending this format for any formula with zinc oxide above 8%.
Formulation Notes for Brand Partners #
What market? What are you expecting on-pack? Those are the first two questions we ask on every sunscreen brief, because the answers determine everything — filter selection, testing protocol, regulatory dossier, and timeline.
If you’re targeting the US with a clean beauty positioning, you’re working within FDA’s approved filter list, which means mineral-only or avobenzone-based systems. Mineral-only at SPF 50 is achievable but requires careful particle engineering and a skin-feel investment that adds cost. If you want SPF 50+ with a lightweight, invisible finish, budget for encapsulated zinc oxide — roughly 2.5× the cost of standard zinc oxide dispersion.
EU launch adds UVA-PF ratio compliance and SCCS ingredient review obligations. If you’re using octocrylene, we’ll flag the current SCCS review status and discuss alternatives. China NMPA registration for sunscreen is a separate process with its own approved filter list and mandatory PFA testing — plan for 12–18 months registration timeline minimum.
PA++++ is achievable on most SPF 50+ formulas we develop, but it requires UVA filter loading to be prioritized from the start, not added as an afterthought. We’ve had projects where the brand locked the SPF 50 formula first, then asked for PA++++ — and the UVA filter adjustment needed to hit that target changed the skin feel enough to require a full texture rework. Start with both targets simultaneously.
Timeline reality: a new broad-spectrum formula from brief to stability-cleared takes 9–14 months if you include full accelerated stability and regulatory testing. Brands that come to us expecting 6 months usually end up at 10.
Frequently Asked Questions #
Q: We want to put “SPF 50+ PA++++” on pack for Japan and the EU — is one formula enough?
Achievable, but it requires deliberate filter selection from day one. For EU, you need UVA-PF ≥ 16.7 (one-third of SPF 50); for Japan PA++++, you need UVA-PF ≥ 16 by JCIA protocol. Those targets are close but the test methods differ. We run both protocols in parallel and design to the higher UVA-PF target — typically UVA-PF ≥ 18 — to give headroom for batch-to-batch variation.
Q: Can we add niacinamide at 5% to our SPF 50 formula?
Yes, and it’s a combination we formulate regularly. Niacinamide is pH-compatible with most sunscreen systems at pH 6.0–7.0, doesn’t interact with organic filters, and adds a brightening claim that works well commercially. The one watch-out: niacinamide can hydrolyze to nicotinic acid at elevated temperatures over time, which causes flushing in some users. We keep storage temperature recommendations at ≤ 30°C on pack for any formula with niacinamide above 3%.
Q: Our last supplier said the formula is “photostable” — how do we verify that?
Ask for the photostability data, not just the claim. The standard test is ISO 24443 — irradiate the formula at 1.2 MED equivalent UV dose, then measure SPF retention. We consider anything below 90% SPF retention post-irradiation a photostability failure. If the supplier can’t provide that data, the formula hasn’t been properly tested. We generate this data internally on every formula before we present it to a brand partner.
Q: We’re a clean beauty brand — can we avoid all synthetic UV filters?
You can, but understand the trade-offs. Mineral-only (zinc oxide + titanium dioxide) formulas are fully achievable at SPF 30 with good aesthetics. SPF 50+ mineral-only with a cosmetically elegant finish requires nano or micronized particles, which triggers EU nano notification requirements and adds cost. At SPF 50+ with standard non-nano zinc oxide, you’re looking at white cast that most consumers won’t accept. We’re not going to tell you it’s impossible — we’re going to tell you what it actually looks like on skin at 20% zinc oxide loading.
Q: How long does stability testing take before we can launch?
Accelerated stability at 40°C/75% RH runs for 12 weeks minimum — that’s the ICH-aligned protocol we use as a proxy for 12 months real-time. We also run a 6-month real-time study in parallel. For regulatory submission in China (NMPA), you need 36-month real-time stability data, which means you’re either launching on accelerated data with a commitment to complete real-time, or you’re waiting 3 years. Most brands launching in China use the accelerated data pathway for initial registration and complete real-time data post-launch.
Have a product concept in mind? Contact our formulation team to request a complimentary brief review.
© 2026 Mastracare.com. All rights reserved.
Unauthorized reproduction or distribution is prohibited.